Stratification of Anatomical Imaging Features Between High-Risk and Non-High-Risk Groups in Neuroblastoma

被引:0
作者
Wang, Haoru [1 ]
Chen, Xin [1 ]
He, Ling [1 ]
Cai, Jinhua [1 ]
机构
[1] Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Dept Radiol,Childrens Hosp,Chongqing Key Lab Child, Minist Educ Key Lab Child Dev & Disorders, 136 Zhongshan Rd 2, Chongqing 400014, Peoples R China
关键词
children; computed tomography; image-defined risk factors; magnetic resonance imaging; neuroblastoma; CLASSIFICATION-SYSTEM; SINGLE;
D O I
10.1177/10732748251315883
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: This study compared anatomical imaging features between high-risk and non-high-risk groups in neuroblastoma with at least one image-defined risk factor (IDRF). It also assessed the diagnostic performance of these features in identifying the high-risk group. Methods: A retrospective analysis of neuroblastoma patients with at least one IDRF was conducted. Imaging features, including estimated tumor volume and IDRFs, were compared between the two groups. The diagnostic performance of these features was assessed using receiver operating characteristic (ROC) curves, and the areas under the ROC curves (AUCs) along with their 95% confidence intervals (CIs) were calculated. Additionally, to internally validate their diagnostic performance, the bootstrap resampling method with 1000 bootstrap resamples was employed. Results: The study included 255 patients (185 high-risk cases, 70 non-high-risk cases). Significant differences were found in estimated tumor volume and IDRF number between the high-risk and non-high-risk groups (P < 0.001). The estimated tumor volume and the IDRF number-based cluster were independent risk factors, and their combination achieved an AUC of 0.801 (95% CI: 0.747-0.848) for high-risk group diagnosis, with the average AUC of the 1000 bootstrap samples of 0.800 (95% CI: 0.798-0.802). In abdominal lesions, specific IDRF categories differed between high-risk and non-high-risk groups (P < 0.05). Conclusion: Our study reveals anatomical imaging differences between high-risk and non-high-risk groups in neuroblastoma with at least one IDRF.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Bronchiectasis following treatment for high-risk neuroblastoma: A case series
    Adams, Madeleine
    Traunecker, Heidi
    Doull, Iolo
    Cox, Rachel
    PEDIATRIC BLOOD & CANCER, 2017, 64 (10)
  • [32] Thiotepa-melphalan myeloablative therapy for high-risk neuroblastoma
    Yamazaki, Fumito
    Yamasaki, Kai
    Kiyotani, Chikako
    Hashii, Yoshiko
    Shioda, Yoko
    Hara, Junichi
    Matsumoto, Kimikazu
    PEDIATRIC BLOOD & CANCER, 2021, 68 (06)
  • [33] Pharmacologic Management of High-Risk Neuroblastoma in Children
    Veena R. Ganeshan
    Nina F. Schor
    Pediatric Drugs, 2011, 13 : 245 - 255
  • [34] The safety of dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma
    Greenwood, Katie L.
    Foster, Jennifer H.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1257 - 1262
  • [35] SPECT/CT MIBG Imaging Is Crucial in the Follow-up of the Patients With High-Risk Neuroblastoma
    Liu, Bin
    Servaes, Sabah
    Zhuang, Hongming
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (04) : 232 - 238
  • [36] Histological features of primary tumors after induction or high-dose chemotherapy in high-risk neuroblastoma
    Tomoro Hishiki
    Hiroshi Horie
    Yasuyuki Higashimoto
    Katsumi Yotsumoto
    Shugo Komatsu
    Yuri Okimoto
    Harumi Kakuda
    Yuichi Taneyama
    Takeshi Saito
    Keita Terui
    Tetsuya Mitsunaga
    Mitsuyuki Nakata
    Hidemasa Ochiai
    Moeko Hino
    Kumiko Ando
    Hideo Yoshida
    Jun Iwai
    Pediatric Surgery International, 2014, 30 : 919 - 926
  • [37] Prediction of High-Risk Neuroblastoma Among Neuroblastic Tumors Using Radiomics Features Derived from Magnetic Resonance Imaging: A Pilot Study
    Kim, Jisoo
    Choi, Young Hun
    Yoon, Haesung
    Lim, Hyun Ji
    Han, Jung Woo
    Lee, Mi-Jung
    YONSEI MEDICAL JOURNAL, 2024, 65 (05) : 293 - 301
  • [38] Ultrahigh-risk Group Within the High-risk Neuroblastoma Category
    Saarinen-Pihkala, Ulla M.
    Jahnukainen, Kirsi
    Wikstrom, Sakari
    Koivusalo, Antti
    Karikoski, Riitta
    Sariola, Hannu
    Hovi, Liisa
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (06) : E254 - E259
  • [39] Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma
    Tas, M. L.
    Reedijk, A. M. J.
    Karim-Kos, H. E.
    Kremer, L. C. M.
    van de Ven, C. P.
    Dierselhuis, M. P.
    van Eijkelenburg, N. K. A.
    van Grotel, M.
    Kraal, K. C. J. M.
    Peek, A. M. L.
    Coebergh, J. W. W.
    Janssens, G. O. R.
    de Keizer, B.
    de Krijger, R. R.
    Pieters, R.
    Tytgat, G. A. M.
    van Noesel, M. M.
    EUROPEAN JOURNAL OF CANCER, 2020, 124 : 47 - 55
  • [40] Rapid prediction of deterioration risk among non-high-risk patients with acute pulmonary embolism at admission: An imaging tool
    Gao, Yizhuo
    Wang, Yu
    Cao, Xia
    Wang, Xiaoxu
    Zheng, Qiang
    Zhao, Hang
    Jia, Dong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 338 : 229 - 236